Rosuvastatin Tablet, Film Coated
Product Images NDC 70518-4296

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 70518-4296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Rosuvastatin 20 mg film-coated tablets packaging label shows a quantity of 45 tablets. The label includes the NDC number 70518-4296-00 and indicates the manufacturer as ScieGen in Hauppauge, NY. The labeler is RemedyRepack Inc., Indiana, PA. Storage instructions specify 20-25°C with permitted excursions.*
FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
A cumulative incidence curve chart comparing Rosuvastatin (Rosuva) and placebo groups over a period of up to 5-6 years. The y-axis shows cumulative incidence in percentage, and the x-axis indicates years. The chart includes hazard ratio (HR 0.56 with 95% CI 0.46-0.69) and a p-value (<0.001). A risk table below the graph shows the number of participants at risk for each group over time.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
A data table comparing the number of cardiovascular-related events between Rosuvastatin 20 mg and placebo groups. It includes endpoints such as primary end point, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization, along with hazard ratios, confidence intervals, and p-values. A hazard ratio plot is shown beside the table.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
A box plot chart showing percent change from baseline in LDL-C for four statin drugs (Rosuvastatin, Atorvastatin, Simvastatin, Pravastatin) at different doses (10, 20, 40 mg, with Atorvastatin and Simvastatin also including 80 mg). The y-axis represents percent change ranging approximately from 0 to -75%, with each drug showing varying distributions of LDL-C reduction.*
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)
Chemical structure diagram of Rosuvastatin calcium, showing the molecular arrangement including the calcium ion (Ca2+) complexed with the Rosuvastatin molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.